Ropes & Gray advised Partners Group on the transaction. Partners Group, one of the largest firms in the global private markets industry, announced its acquisition of...
Partners Group’s Acquisition of Majority Stake in Fairjourney Biologics
Blackstone Life Sciences’ $750 Million Collaboration with Moderna
Ropes & Gray represented Blackstone Life Sciences in the transaction. Blackstone Life Sciences (NYSE:BX) (“Blackstone”) announced a collaboration with Moderna, Inc. (NASDAQ: MRNA, “Moderna”) through a development and...
Intrinsic Medicine’s Business Combination Agreement with Phoenix Biotech Acquisition Corp.
Ropes & Gray advised Intrinsic, while Goodwin Procter advised PBAX on the deal. Intrinsic Medicine, Inc., a therapeutics company leveraging human milk biology to transform Gut-Brain...
IDRx’s $122 Million Series A Financing
Ropes & Gray advised IDRx on the deal. Clinical stage precision cancer biopharmaceutical company IDRx announced licensing transactions with Germany-based Merck KGaA and Blueprint Medicines to...
ConvaTec Group’s Acquisition of Triad Life Sciences
Ropes & Gray represented ConvaTec Group in the transaction. ConvaTec Group, a global medical solutions company, executed its acquisition of medical device company, Triad Life Sciences. ...
Blackstone Life Sciences’ $250 Million Investment in Cellex Group
Noerr and Morgan, Lewis & Bockius advised Cellex Cell Professionals GmbH on the deal. Ropes & Gray advised Blackstone Life Sciences. The Dresden-based Cellex Group announced...